New Molecule May Open New Therapeutic Pathway Against Brain Cancer
Researchers at Brown University Health have identified a molecule that could potentially alter how glioblastoma responds to treatment. Glioblastoma is the deadliest and most prevalent form of brain cancer affecting adults, with a five-year survival rate of just 5%-10%. The molecule, designated miR-181d, is a type of microRNA that appears to work through two separate biological mechanisms. Early findings suggest it could open treatment to patients currently beyond the reach of existing therapies. Brown University Health's study began with an unusual patient group: individuals who survive the disease far longer than their prognosis would predict. The team analyzed hundreds of…

